Lu H R, Vandeplassche G, Wouters L, Borgers M
Department of Cardiovascular Pharmacology, Janssen Research Foundation, Beerse, Belgium.
Arch Int Pharmacodyn Ther. 1989 Sep-Oct;301:165-81.
The cardioprotective effects of the beta-blocking drugs (dl-nebivolol, d-nebivolol, propranolol, atenolol, dilevalol and pindolol) were tested in the isolated working rabbit heart. The effects of l-nebivolol, having little beta-adrenoceptor blocking activity, were also studied. The hearts were subjected to 25 min ischemia, followed by 30 min of reperfusion. In solvent-treated hearts, ischemia resulted in a considerable loss of function. The mean functional recovery of one of the most sensitive parameters, i.e. aortic flow, was only 6%. Pretreatment either with dl-nebivolol, d-nebivolol, l-nebivolol or propranol significantly improved cardiodynamic function. Recovery after pretreatment with atenolol, dilevalol and pindolol (less than 10 mg/l) was not significantly improved when compared to solvent-treated hearts. The results suggest that the protective effects of some beta-blockers are most probably not related to beta-adrenoceptor blocking activity.
在离体工作兔心脏中测试了β受体阻滞剂(消旋奈必洛尔、右旋奈必洛尔、普萘洛尔、阿替洛尔、地来洛尔和吲哚洛尔)的心脏保护作用。还研究了几乎没有β肾上腺素能受体阻断活性的左旋奈必洛尔的作用。心脏经历25分钟的缺血,随后30分钟的再灌注。在溶剂处理的心脏中,缺血导致功能显著丧失。最敏感参数之一即主动脉流量的平均功能恢复仅为6%。用消旋奈必洛尔、右旋奈必洛尔、左旋奈必洛尔或普萘洛尔预处理可显著改善心脏动力学功能。与溶剂处理的心脏相比,用阿替洛尔、地来洛尔和吲哚洛尔(低于10mg/l)预处理后的恢复没有显著改善。结果表明,一些β受体阻滞剂的保护作用很可能与β肾上腺素能受体阻断活性无关。